Description- Summary In the 2014 base year, the global PAD market was worth approximately $543.4m, including both branded and generic drugs. By 2024, GlobalData expects that the global PAD market will experience significant expansion, with a Compound Annual Growth Rate (CAGR) of approximately 4.15%, equating to around $816.3m. The dramatic increase in the value of the overall global PAD therapeutics market will be partly attributable to the launch of several PAD drugs currently in late-stage pipeline development, which GlobalData believes have extraordinary potential. These include the novel antithrombotic pharmacological agents, Merck & Co.s Zontivity (vorapaxar), AstraZenecas Brilinta (ticagrelor), and Bayer and Janssens (a subsidiary of Johnson & Johnson) Xarelto (rivaroxaban), which have the capacity to reform the antiplatelet and anticoagulatory PAD treatment landscape. To Free Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=816335

1. Peripheral Artery Disease ­ 5EU China Drug Forecast and
Market Analysis to 2024, Analysis, Insights, outlook and
survey report
Researchmoz.us added new research on "Peripheral Artery Disease - 5EU
China Drug Forecast and Market Analysis to 2024". The Report covers
current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect.
0

2. Description-
Summary
In the 2014 base year, the global PAD market was worth approximately $543.4m,
including both branded and generic drugs. By 2024, GlobalData expects that the
global PAD market will experience significant expansion, with a Compound Annual
Growth Rate (CAGR) of approximately 4.15%, equating to around $816.3m. The
dramatic increase in the value of the overall global PAD therapeutics market will be
partly attributable to the launch of several PAD drugs currently in late-stage
pipeline development, which GlobalData believes have extraordinary potential.
These include the novel antithrombotic pharmacological agents, Merck & Co.s
Zontivity (vorapaxar), AstraZenecas Brilinta (ticagrelor), and Bayer and Janssens (a
subsidiary of Johnson & Johnson) Xarelto (rivaroxaban), which have the capacity to
reform the antiplatelet and anticoagulatory PAD treatment landscape.
To Free Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?
type=S&repid=816335
1

3. Total 5EU sales for the PAD therapeutics market in 2014 was approximately
$198.8m. By 2024, sales of drugs that are used to relieve the symptoms of PAD will
decline quite dramatically. This group of medicines will only contribute
approximately 5% to total 5EU PAD sales by the end of the forecast period.
*This is an on-demand report and will be delivered within 24 hrs. (excluding
weekends) of the purchase.
Scope
- Overview of PAD including epidemiology, etiology, symptoms, diagnosis,
pathology and treatment guidelines as well as an overview on the competitive
landscape.
- Detailed information on the key drugs in 5EU including product PADcription,
safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in 5EU from 2014-2024.
- Analysis of the impact of key events as well the drivers and restraints affecting
5EU PAD market.
2

4. To Enquire Regarding This Report @ http://www.researchmoz.us/enquiry.php?
type=E&repid=816335
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a
robust return
- Stay ahead of the competition by understanding the changing competitive
landscape for PAD.
- Effectively plan your M&A and partnership strategies by identifying drugs with the
most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of
drug performance
- Obtain sales forecast for drugs from 2014-2024 in 5EU.
For More Information Kindly Contact:
ResearchMoz Global Pvt. Ltd.
90 State Street,
3

5. Albany, NY 12207,
United States
http://www.researchmoz.us,
Blog - http://bit.ly/2b1Ayn6
866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,
Email to: sales@researchmoz.us,
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our
database is composed of current market studies from over 100 featured publishers worldwide. Our
market research databases integrate statistics with analysis from global, regional, country and company
perspectives. ResearchMoz’s service portfolio also includes value-added services such as market
research customization, competitive landscaping, and in-depth surveys, delivered by a team of
experienced Research Coordinators.
FOR MORE INFORMATION
Chemicals &
Materials
Consumer Goods Energy Food &
Beverages
Technology
4

6. Medical Devices Pharma &
Healthcare
Automotive Electronics Manufacturing &
Construction
THANK YOU !
5

7. ….Always Well Wisher“RESEARCHMOZ”
6